Lidocaine Patent Expiration

Lidocaine is Used for managing pain associated with post-herpetic neuralgia. It was first introduced by Astrazeneca Lp in its drug Xylocaine on Approved Prior to Jan 1, 1982. Other drugs containing Lidocaine are Lidoderm, Ztlido, Dentipatch. 30 different companies have introduced drugs containing Lidocaine.


Lidocaine Patents

Given below is the list of patents protecting Lidocaine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lidoderm US5741510 Adhesive patch for applying analgesic medication to the skin Mar 30, 2014

(Expired)

Teikoku Pharma Usa
Lidoderm US5827529 External preparation for application to the skin containing lidocaine Oct 27, 2015

(Expired)

Teikoku Pharma Usa
Ztlido US10765640 Non-aqueous patch May 10, 2031 Scilex Pharms
Ztlido US10765749 Non-aqueous patch May 10, 2031 Scilex Pharms
Ztlido US11278623 Non-aqueous patch May 10, 2031 Scilex Pharms
Ztlido US11786455 Non-aqueous patch May 10, 2031 Scilex Pharms
Ztlido US11793766 Non-aqueous patch for the relief of pain May 10, 2031 Scilex Pharms
Ztlido US9283174 Non-aqueous patch May 10, 2031 Scilex Pharms
Ztlido US9925264 Non-aqueous patch May 10, 2031 Scilex Pharms
Ztlido US9931403 Non-aqueous patch May 10, 2031 Scilex Pharms


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lidocaine's patents.

Given below is the list recent legal activities going on the following patents of Lidocaine.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 21 Feb, 2024 US10765640
Payment of Maintenance Fee, 4th Year, Large Entity 21 Feb, 2024 US10765749
Mail Patent eGrant Notification 24 Oct, 2023 US11793766
Patent eGrant Notification 24 Oct, 2023 US11793766
Recordation of Patent eGrant 24 Oct, 2023 US11793766
Recordation of Patent Grant Mailed 24 Oct, 2023 US11793766
Email Notification 24 Oct, 2023 US11793766
Patent Issue Date Used in PTA Calculation 24 Oct, 2023 US11793766
Patent eGrant Notification 17 Oct, 2023 US11786455
Email Notification 17 Oct, 2023 US11786455



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Lidocaine Generics

Several generic applications have been filed for Lidocaine. The first generic version for Lidocaine was by Fougera Pharmaceuticals Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Jun 18, 2024.

Given below is the list of companies who have filed for Lidocaine generic.


1. SEPTODONT INC

Septodont Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Septodont Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Prescription TOPICAL AT May 23, 2011


2. TARO

Taro Pharmaceuticals Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Prescription TOPICAL AT Approved Prior to Jan 1, 1982


3. AMNEAL

Amneal Pharmaceuticals Llc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% patch Prescription TOPICAL AB Aug 24, 2020


4. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Prescription TOPICAL AT Dec 11, 2018


5. COSETTE

Cosette Pharmaceuticals Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Cosette.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Discontinued TOPICAL N/A Dec 12, 2018


6. AMNEAL PHARMS

Amneal Pharmaceuticals has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Prescription TOPICAL AT Aug 7, 2015


7. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Prescription TOPICAL AT Nov 23, 2018


8. QUAGEN

Quagen Pharmaceuticals Llc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Quagen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Prescription TOPICAL AT Apr 20, 2021


9. ENCUBE

Encube Ethicals Private Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Encube.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Discontinued TOPICAL N/A Feb 1, 2016


10. TEVA PHARMS USA

Teva Pharmaceuticals Usa Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Discontinued TOPICAL N/A Jan 16, 2018


11. FOUGERA PHARMS INC

Fougera Pharmaceuticals Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5%

(reference standard)

(reference listed drug)

ointment Prescription TOPICAL AT Approved Prior to Jan 1, 1982


12. CARLISLE

Carlisle Laboratories Inc has filed for 1 generic for Lidocaine. This 5% version comes by the name ALPHACAINE. Given below are the details of the strengths of this generic introduced by Carlisle.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Discontinued TOPICAL N/A Approved Prior to Jan 1, 1982


13. IBSA

Ibsa Institut Biochimique Sa has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Ibsa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% patch Prescription TOPICAL AB Apr 30, 2020


14. ACTAVIS LABS UT INC

Actavis Laboratories Ut Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Actavis Labs Ut Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% patch Prescription TOPICAL AB Aug 23, 2012


15. BELMORA LLC

Belmora Llc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Belmora Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Discontinued TOPICAL N/A Approved Prior to Jan 1, 1982


16. AILEX PHARMS LLC

Ailex Pharmaceuticals Llc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Ailex Pharms Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Discontinued TOPICAL N/A Oct 17, 2019


17. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Prescription TOPICAL AT Mar 16, 2020


18. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Prescription TOPICAL AT Sep 9, 2016


19. NAL PHARM

Nal Pharmaceutical Group Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Nal Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% patch Prescription TOPICAL AB Apr 29, 2021


20. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Prescription TOPICAL AT Jan 5, 2021


21. RISING

Rising Pharma Holdings Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Discontinued TOPICAL N/A Sep 20, 2017


22. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Prescription TOPICAL AT Jun 18, 2024


23. MYLAN TECHNOLOGIES

Mylan Technologies Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Mylan Technologies.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% patch Prescription TOPICAL AB Aug 7, 2015


24. VITRUVIAS THERAP

Vitruvias Therapeutics Llc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Vitruvias Therap.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Discontinued TOPICAL N/A Sep 25, 2017


25. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% ointment Prescription TOPICAL AT Mar 10, 2017


26. NOVEN PHARMS INC

Noven Pharmaceuticals Inc has filed for 1 generic for Lidocaine. Given below are the details of the strengths of this generic introduced by Noven Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5% patch Discontinued TOPICAL N/A Dec 1, 2020